Effect of Rovatirelin in Patients with Cerebellar Ataxia: Two Randomised

Total Page:16

File Type:pdf, Size:1020Kb

Effect of Rovatirelin in Patients with Cerebellar Ataxia: Two Randomised Neurodegeneration J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-322168 on 14 January 2020. Downloaded from ORIGINAL RESEARCH Effect of rovatirelin in patients with cerebellar ataxia: two randomised double- blind placebo- controlled phase 3 trials Masatoyo Nishizawa ,1 Osamu Onodera,2 Akihiro Hirakawa,3 Yoshitaka Shimizu,4 Masayuki Yamada,5 on behalf of the Rovatirelin Study Group ► Additional material is ABSTRact atrophy (MSA) show cerebellar symptoms and published online only. To view Objective To investigate the efficacy of rovatirelin, a extracerebellar symptoms. The presence of extra- please visit the journal online cerebellar symptoms also contributes to a patient’s (http:// dx. doi. org/ 10. 1136/ thyrotropin-releasing hormone analogue, for ataxias in jnnp- 2019- 322168). patients with spinocerebellar degeneration (SCD). disability and may interfere with evaluation of the Methods Two multicentre, randomised, double- blind, severity of cerebellar ataxia. Therefore, it is consid- 1Brain Research Institute, placebo- controlled phase 3 studies (KPS1301, KPS1305) ered more useful to evaluate the effect of a drug Niigata University, Niigata, enrolled patients with predominant cerebellar ataxia, on cerebellar ataxia in patients with predominant Japan 2Department of Neurology, including SCA6, SCA31 or cortical cerebellar atrophy. cerebellar symptoms. Brain Research Institute, Niigata KPS1301 enrolled patients with truncal ataxia and Thyrotropin- releasing hormone (TRH) is a University, Niigata, Japan KPS1305 enrolled patients with truncal and limb ataxia. hypothalamic hormone that promotes thyroid- 3 Department of Biostatistics and Each study included 4 weeks of pretreatment, a 28-week stimulating hormone and prolactin (PRL) release Bioinformatics, The University from the pituitary gland, and acts broadly on the of Tokyo, Graduate School of or 24-week treatment period and 4 weeks of follow-up . Medicine, Tokyo, Japan Patients were randomised (1:1:1) to rovatirelin (1.6 or central nervous system to activate several neurotrans- 4Strategic Alliance Department, 2.4 mg) or placebo in KPS1301, and randomised (1:1) mitters.4–7 TRH has been shown to improve ataxia Kissei Pharmaceutical Co., Ltd, to rovatirelin 2.4 mg or placebo in KPS1305. The primary in an ataxia mouse model with a CACNA1A muta- Tokyo, Japan endpoint was change in Scale for the Assessment and tion, the causative gene for SCA6.8 9 In a 2- week, 5Clinical Data Science Department, Kissei Rating of Ataxia (SARA) total scores. Pooled analysis was double- blind, placebo-controlled trial in 254 SCD copyright. Pharmaceutical Co., Ltd, Tokyo, performed in patients who met the SARA recruitment patients, the efficacy of a TRH analogue (TRH Japan criteria of KPS1305. tartrate) was demonstrated in patients with predom- Results From October 2013 to May 2014, KPS1301 inantly ataxic forms of SCD.10 Thus, the first TRH Correspondence to enrolled 411 patients; 374 were randomised to analogue was approved in Japan in 1985 for the Dr Masatoyo Nishizawa, rovatirelin 1.6 mg (n=125), rovatirelin 2.4 mg (n=126) or treatment of ataxia associated with SCD. However, Department of Neurology, Brain Research Institute, Niigata placebo (n=123). From November 2016 to August 2017, in the previous clinical trial, the diagnostic criteria University, Niigata 951-8585, KPS1305 enrolled 241 patients; 203 were randomised for SCD were not consistent with recent diagnostic Japan; nishizawamasatoyo@ to rovatirelin 2.4 mg (n=101) or placebo (n=102). The criteria. Further, over 60% of patients with the gmail. com primary endpoint showed no significant difference predominantly ataxic forms of SCD had olivopon- tocerebellar atrophy, and the drug effects were not Received 4 October 2019 between rovatirelin and placebo in these two studies. Revised 22 December 2019 In the pooled analysis (n=278), the difference between assessed using an ataxia rating scale alone. Finally, http://jnnp.bmj.com/ Accepted 25 December 2019 rovatirelin 2.4 mg (n=140) and placebo (n=138) the duration of the trial was only 2 weeks. There- Published Online First 14 was –0.61 (–1.64 vs –1.03; 95% CI –1.16 to –0.06; fore, well-designed double- blind trials were consid- January 2020 p=0.029) in the adjusted mean change in the SARA total ered necessary to demonstrate the efficacy of new score. drug candidates for cerebellar ataxia.11 12 Conclusions Rovatirelin is a potentially effective Rovatirelin is a new TRH analogue,13 which treatment option for SCD. showed higher affinity for human TRH recep- Trial registration number NCT01970098; tors and greater absorption and transition into on September 24, 2021 by guest. Protected NCT02889302 and stability in the brain than the existing TRH analogue, taltirelin.14 15 The effects of rovatirelin on the ataxic rolling Nagoya mice, which carry a mutation in the CACNA1A gene, were more potent INTRODUCTION and lasted longer than those of taltirelin (data on Spinocerebellar degeneration (SCD) is a neurode- file). To investigate the efficacy and safety of rovat- generative disease that is characterised by progres- irelin for the treatment of cerebellar ataxia, we © Author(s) (or their sive cerebellar ataxia.1 2 The main symptoms of employer(s)) 2020. Re- use performed two large- scale, randomised, double- permitted under CC BY-­NC. No SCD are gait ataxia, standing instability, limb ataxia 3 blind, phase 3 studies in patients with predominant commercial re-use . See rights and dysarthria. In addition, pyramidal tract, extra- cerebellar symptoms of SCD. and permissions. Published pyramidal or peripheral nervous symptoms can by BMJ. occur in patients with some types of SCDs.3 Hered- To cite: Nishizawa M, itary SCA6, SCA31 and sporadic cortical cerebellar METHODS Onodera O, Hirakawa A, et al. atrophy (CCA) mainly show cerebellar symptoms, Study design and participants J Neurol Neurosurg Psychiatry while hereditary SCA1, SCA2, SCA3 (Machado- Two similar multicentre, randomised, double- blind, 2020;91:254–262. Joseph disease) and sporadic multiple system placebo- controlled, phase 3 studies (KPS1301 254 Nishizawa M, et al. J Neurol Neurosurg Psychiatry 2020;91:254–262. doi:10.1136/jnnp-2019-322168 Neurodegeneration J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-322168 on 14 January 2020. Downloaded from and KPS1305) were conducted in Japanese patients with SCD. Efficacy and safety were evaluated during hospital visits every Patients were enrolled from 86 hospitals in Japan between 9 4 weeks. At weeks 0 through 24, SARA (Japanese version) was October 2013 and 30 May 2014 in KPS1301 and from 62 hospi- used to assess the degree of ataxia. Each patient was assessed tals in Japan between 15 November 2016 and 1 August 2017 in for SARA by the same investigator, who was a board- certified KPS1305. neurologist of the Japanese Society of Neurology. Because differ- Both studies included patients aged ≥20 years with only ences in SARA assessment between investigators cannot be elim- predominant cerebellar symptoms of SCD (CCA or geneti- inated in large- scale, multicentre trials, the investigators were cally confirmed SCA6 or SCA31). The diagnosis of CCA was trained using a video of the SARA assessment method to reduce mainly based on the idiopathic cerebellar ataxia diagnostic the variability in SARA assessments. Patient quality of life (QoL) criteria proposed by Yoshida et al.16 Briefly, patients with slowly was self- assessed using the Japanese version of the Short Form-8 progressive adult- onset cerebellar ataxia and with no first- degree (SF-8) questionnaire at weeks 0 through 24.20 or second- degree relatives with ataxia were enrolled, while patients with autoimmune- mediated, metabolic, alcoholic and Outcomes drug- induced ataxia were excluded. In addition, patients with The primary endpoint was change in the SARA total score from MSA were carefully excluded based on the second consensus baseline to the time point of final evaluation. The final eval- statement for the diagnosis of MSA.17 A detailed diagnostic flow uation was defined as the latest evaluation, excluding missing diagram of CCA is shown in online supplementary figure 1. data. Secondary efficacy endpoints were the SARA total score, The KPS1301 study included patients with truncal ataxia individual SARA scores and SF-8 scores at each evaluation time (Scale for the Assessment and Rating of Ataxia (SARA)18 19 total point. Safety endpoints included adverse events (AEs), vital score of ≥6 and SARA gait score of 2–6). The KPS1305 study signs, body weight, 12- lead ECG, clinical laboratory tests and included patients with both truncal and limb ataxia (SARA gait endocrinology tests (thyroid stimulating hormone (TSH), free score of 2–6, stance score of ≥2 and scores of ≥1 for the finger triiodothyronine (FT3), free thyroxine (FT4) and PRL). Investi- chase, nose- finger and fast alternating hand movements tests gators evaluated AEs for severity (mild, moderate or severe) and (patients with scores of ≥1 on unilateral tests were included if for causal relationships with the test agents. tests were not feasible on the right or left side for some reason other than the primary disease)). Exclusion criteria were: secondary ataxia (eg, cerebrovas- Statistical analyses cular disorder, brain tumour, multiple sclerosis, hypothyroidism, For the KPS1301 study, assuming a difference in the change drug- induced, paraneoplastic syndrome); suspected alcoholic in the SARA total score between the rovatirelin group and the ataxia; motor disorder due to musculoarticular disease; cogni- placebo group of −0.75, and a common SD of 2.0, a sample size copyright. tive impairment, depression or other mental diseases and a diag- of 113 randomly assigned patients was calculated as sufficient nosis of thyrotoxicosis. In the KPS1305 study, patients who had to provide 80% power with a two- sided 5% significance level. participated in a rovatirelin study ≥2 years ago were eligible to In the KPS1305 study, a sample size of 87 randomly assigned enrol; however, this group of patients was restricted to ≤30% of patients was calculated as sufficient to provide 80% power with the total number of patients enrolled in KPS1305.
Recommended publications
  • Hopeful Future for Japan
    As of December 20, 2017 Hopeful future for Japan Nippon Healthcare Investment Corporation Presentation Material for The 7th Fiscal Period Ended October 2017 Securities code : 3308 Contents Disclaimer Continuous Evaluation of Operators and Monitoring System 19 Highlights of 7th Fiscal Period (Ended October 2017) 3 Implementation of Monitoring and Section 1 Relationships with Operators 20 Operating Results for 7th Fiscal Period Introduction of Operators 21 Operator Initiatives (AI and System Introduction) 22 Operating Results for 7th Fiscal Period 5 Forecast of Operating Results for 8th Fiscal Period Section 4 and 9th Fiscal Period 6 Financial Status Distribution per Unit 7 Status of Interest-Bearing Liabilities Section 2 (as of October 31, 2017)・・・・・・・・・・・・・・・・・・・・ 24 External Growth Policy on Distributions in Excess of Earnings/Index including NHI 25 Change in Asset Size 9 Overview of the Unitholder Benefits Program・・・・・・・・・・・・・ 26 Sourcing Route 10 ・・・・・・・・・・・・・・ Section 3 Section 5 Portfolio Analysis Environment Surrounding Healthcare Industry Portfolio List (as of October, 2017) 12 Surrounding Status of Healthcare Facilities : Status of Portfolio: Change in Occupancy Rates 13 Progress of aging society 29 Remaining Lease Contract Period of Each Property 14 Market Size by Segment( as of June 2016) 30 Status of Portfolio: Fee Systems of Facilities 15 History of Revisions to Nursing Care Fees 31 Status of Portfolio (as of October 31, 2017) 16 Portfolio Resident Attributes (as of October 31, 2017) 17 Appendix Properties Renovated in the 7th Fiscal Period 18 This document is not material disclosed in compliance with the Financial Instruments and Exchange Act or any regulation of similar nature, nor is it intended for the purposes of solicitation.
    [Show full text]
  • Subject Index
    Subject Index Aalto, Alvar, 22 Art Shed Southbank Architectural Com- bearing, solar angle diagrams, 334 Ackerman Student Union, University of petition, 2006, 383 Berkeley Art Museum and Pacific Film California at Los Angeles, Cali- Asia Society, Hong Kong Center, China, Archive, Berkeley, California, fornia, 250 410, 411 197 Adelaide University, South Australia, assembly drawing, linear perspective Bernal Heights residence, San Fran- School of Architecture, Land- drawing, 311 cisco, California, 262 scape Architecture and Urban Atocha Station, Madrid, Spain, 75 B FIVE STUDIO, 550 Design, 499 audience, portfolio, 463–64 Bilbao Effect, 120 Adelman/Liano residence, Santa Moni- August Wilson Center for African Ameri- BIM (building information modeling), ca, California, 207 can Culture, Pittsburgh, Penn- capabilities of, 93–94 Adobe Photoshop, 63 sylvania, 284 bird’s eye perspective African American Museum of Slavery, Aulenti, Gaetana, 22 linear perspective drawing, 246–47, Rockville, Maryland, 429 automobile 298–301 Aga Han Museum, Toronto, Canada, conceptual sketching, 73 one-point perspective from above, 242 representational drawing, 26–29 linear perspective drawing, Alaska, University of, Fairbanks, 198 auxiliary views, multiview-drawings, 177 248–49 alternatives, conceptual diagramming axes addition, orthographic and paraline underside perspective with, linear and sketches, 40, 44–45 drawing, 195 perspective drawing, 303 altitude, solar angle diagrams, 334 axial lines, orthographic and paraline Birkerts, Gunnar, 42, 69, 150 American Museum
    [Show full text]
  • Guia2-Oriente.Pdf
    Facultad de Arquitectura UDELAR Montevideo | Uruguay GRUPO DE VIAJE 2013 ARQUITECTURA RIFA G06 EQUIPO DOCENTE Adriana Barreiro Jorge Casaravilla Gustavo Hiriart Pablo Kelbauskas Bernardo Martín Ximena Rodríguez Soledad Patiño Ernesto Spósito MÓDULO 02 ORIENTE DOCENTES MÓDULO 02 Adriana Barreiro Ernesto Spósito Ximena Rodríguez Nota importante: Las Guías de los Grupos de Viaje de la Facultad de Arquitectura de la Universidad de la República son el resultado del trabajo de sucesivos Equipos Docentes Directores y generaciones de estudiantes. En particular, el material contenido en las presentes Guías fue compilado por el Grupo de Viaje Generación 2005 y su Equipo Docente Director del Taller Danza, quienes realizaron su viaje de estudios en el año 2012. Este material ha sido editado y adaptado al proyecto académico del Grupo de Viaje Generación 2006, cuyo viaje de estudios se realizará en el año 2013. Facultad de Arquitectura UDELAR GRUPO DE VIAJE 2012 ARQUITECTURA RIFA G05 EQUIPO DOCENTE Taller Danza Marcelo Danza Lucía Bogliaccini Luis Bogliaccini Diego Capandeguy Marcos Castaings Martín Delgado Andrés Gobba Lucas Mateo Nicolás Newton Natalia Olivera Felipe Reyno Thomas Sprechmann Marcelo Staricco MÓDULO 02 ORIENTE DOCENTES MÓDULO 02 Tomás Sprechman Diego Capandeguy Nicolás Newton GRUPO DE TRABAJO Natalie Cordero Mariana García Etcheverry Bruno La Buonora Magdalena Ponce de León Katia Sei Fong Santiago Serrano Sofía Damiani Mariano García Patricia Izaurralde JAPÓN DatoS GENERALES: Superficie: 37.800 km2. (Con menos del 7% del suelo urbanizable) Población: 128 .100.000 (2010). (Es la décima más grande del mundo) Densidad de Población: 3.336 habitantes por km2 Territorio: Archipiélago, con cuatro islas principales que forman el 97% de la superficie total del país, y con 6.848 islas menores adyacentes.
    [Show full text]
  • English Program, Friday, February 15
    The 49th Annual Meeting of the Japanese Society for Replacement Arthroplasty Feb.15(Fri.) Feb.15(Fri.) Day 1 Program of the 49th Annual Meeting of Day 1 the Japanese Society for Replacement Arthroplasty Day 2 Feb.16(Sat.) Friday, February 15, Room 1 8:00~8:10 Opening Ceremony ‌ Room 1 Room 1 8:10~9:40 Panel Discussion 1 ‌Implant designs and biomechanics of TKA Room 2 Moderators:Hiromasa…MIURA,…Shuichi…MATSUDA 1-1-PD1-01 Effect…of…implants…design…on…in…vivo…kinematics…after…total…knee…arthroplasty Dept. of Orthop. Biomaterial Sci., Osaka Univ. Tetsuya TOMITA, et al ...... 292 Room 3 1-1-PD1-02 Improvement…of…TKA…design…based…on…kinematic…analysis Second Dept. of Orthop. Surg., Dokkyo Medical Univ. Saitama Medical Center/ Dept. of Orthop. Surg., Medical Hospital, Room 4 Tokyo Medical and Dental Univ. Toshifumi WATANABE, et al ...... 292 1-1-PD1-03 TKA…design…from…the…point…of…view…of…3D…morphology…and…kinematics Dept. of Orthop. Surg., Niigata Medical Center Takashi SATO, et al ...... 293 Room 5 1-1-PD1-04 Design…and…biomechanics…of…posterior…stabilized…TKA Dept. of Orthop. Surg., Osaka City Univ. Yukihide MINODA, et al ...... 293 1-1-PD1-05 Total…Knee…Artoroplasty…Design…based…on…Computer…Simulation…analyses Room 6 Dept. of Orthop. Surg., Kyoto Univ. Shinichi KURIYAMA, et al ...... 294 1-1-PD1-06 TKA…design…-Effect…evaluation…and…development…of…next…generation…TKA- Dept. of Orthop. Surg., Ehime Univ. Kazunori HINO, et al ...... 294 Room 7 9:45~11:15 Panel Discussion 2 ‌The facts of THA surgery on the basis of spino-pelvic alignment Room 8 Moderators:Masaaki…MAWATARI,…Yutaka…INABA 1-1-PD2-01 Stress…distribution…for…asetabulum…according…with…the…alignment…of…pelvis…-…spine Faculty of Health and Sport Sciences, Room 9 University of Tsukuba Shumpei MIYAKAWA, et al .....
    [Show full text]
  • Watanabe, Tokyo, E
    Edition Axel Menges GmbH Esslinger Straße 24 D-70736 Stuttgart-Fellbach tel. +49-711-574759 fax +49-711-574784 Hiroshi Watanabe The Architecture of Tokyo 348 pp. with 330 ill., 161,5 x 222 mm, soft-cover, English ISBN 3-930698-93-5 Euro 36.00, sfr 62.00, £ 24.00, US $ 42.00, $A 68.00 The Tokyo region is the most populous metropolitan area in the world and a place of extraordinary vitality. The political, economic and cultural centre of Japan, Tokyo also exerts an enormous inter- national influence. In fact the region has been pivotal to the nation’s affairs for centuries. Its sheer size, its concentration of resources and institutions and its long history have produced buildings of many different types from many different eras. Distributors This is the first guide to introduce in one volume the architec- ture of the Tokyo region, encompassing Tokyo proper and adja- Brockhaus Commission cent prefectures, in all its remarkable variety. The buildings are pre- Kreidlerstraße 9 sented chronologically and grouped into six periods: the medieval D-70806 Kornwestheim period (1185–1600), the Edo period (1600–1868), the Meiji period Germany (1868–1912), the Taisho and early Showa period (1912–1945), the tel. +49-7154-1327-33 postwar reconstruction period (1945–1970) and the contemporary fax +49-7154-1327-13 period (1970 until today). This comprehensive coverage permits [email protected] those interested in Japanese architecture or culture to focus on a particular era or to examine buildings within a larger temporal Buchzentrum AG framework. A concise discussion of the history of the region and Industriestraße Ost 10 the architecture of Japan develops a context within which the indi- CH-4614 Hägendorf vidual works may be viewed.
    [Show full text]
  • 1991-61 Nacsis-Cat
    Inv.Nr. ausgeliehen von: Anmerkung A/B Titel Autorenname 1991-61 500 NACSIS-CAT (12.12.2007) Sch Innovationspotential in der Fertigungstechnik Schöning, Karl - Viktor von Produktionstechnik Berlin; Bd. 19 1990-261 500 NACSIS-CAT (28.09.2005) Nih Shin sangyô ron: Nyû furontia (=new frontier) e no Nihon keizai shinbun sha / Nihon Keizai senryaku Shimbun, Inc. (Hrsg.) 1990-312 500 NACSIS-CAT (19.10.2005) Ish Gijutsu shakai no "katachi" o enshutsu suru: Shisutemu Ishii, Takemochi; Etori, Akio (=system) kôgaku ga egaku gijutsu to ningen 1990-314 500 NACSIS-CAT (19.10.2005) Shi Seimei ni jôhô o yomu: Baiohoronikusu (=bioholonics) Shimuzu, Hiroshi; Etori, Akio ga egaku atarashii jôhô zô 1990-315 500 NACSIS-CAT (19.10.2005) Yos Robotto (=robot) ga machi o aruku hi: Katai kikai kara Yoshikawa, Hiroyuki; Tachibana, yawarakai kikai e Takashi 1990-316 500 NACSIS-CAT (19.10.2005) Hor Tenkan suru baiotekunorojî (=biotechnology): DNA no Horikoshi, Kôki; Taniguchi, Tadatsugu kaidoku kara seimei genshô no kaimei e 1990-317 500 NACSIS-CAT (19.10.2005) Kol Jinkô zôki ni mirai o miru: Kami no tsukurareshi mono Kolff, Willem Johan; Nose, Yukihiko to hito no tsukurishi mono 1990-318 500 NACSIS-CAT (19.10.2005) Tak Kôbunshi to iryô Takemoto, Kiichi (Hrsg.); Sunamoto, Junzô (Hrsg.); Akashi, Mitsuru (Hrsg.); 1990-319 Tsuruta, Teiji; Imanishi, Yukio; Gen, 500 NACSIS-CAT (19.10.2005) Nih Iryô shindan ni okeru haitekunorojî (=high technology) Nihon kôgaku kai (Hrsg.); Atsumi, Kazuhiko; Iinuma, Takeshi; Iinuma, 1990-320 Kazuhiro; Tateno, Yukio; 500 NACSIS-CAT (19.10.2005)
    [Show full text]
  • Litteraturliste
    LITTERATURLISTE „Aoyama Technical College“ in Architectural 1996, pp. 110-27. „From a Talk with Hiroshi Hara“ in Mitsumasa, Hara, H.: „Architecture and Individuality“ in Review 1136 okt. 1991, pp. 45-49. Choudhury, S. & Clavijo, C.: „Machiya. A Survey F. (Ed.): Architecture Riffle 006: Umeda Japan Architect 6/1966, pp. 87-107. „Aoyama Technical College“ in Japan Architect of Traditional Japanese Urban Houses“ in Sky Building Sky Building, Toto, Tokyo Hara, H.: „500Mx500Mx500M Cube“ in GA Ar- 2/1991, pp. 160-63. Japan Architect 1/1972, pp. 91-104. 1993. chitect 13: Hiroshi Hara, A.D.A. Edita, „Amusement Complex <H>“ in Japan Archi- Cooper, M. (overs. & Ed.): This Island of Ja- GA Architect 9: Shin Takamatsu, A.D.A. Edita, Tokyo 1990, pp. 240-43. tect 1/1994, pp. 170-73. pan. João Rodrigues’ Account of 16th- Tokyo 1990. Hara, H.: „On the ‘Drifting Space’ and the Ar- Bellini, M.: „Architecture and Cities“ in Japan century Japon, Kodansha International, GA Architect 13: Hiroshi Hara, A.D.A. Edita, chitectural Forms“ in Japan Architect Architect 3/1992, pp. 172-79 Tokyo & New York 1973. Tokyo 1990. 3/1993, pp. 26-31. Bellini, M.: „Tokyo Design Center“ in Japan Davies, C.: „Office Interiors“ in Davies, C. & Gion. Suina asobi no sekai, (Gion. Den ele- Hara, H.: „Extraterrestrial Architecture Project“ Architect 3/1992, pp. 180-91 Lambot I.: Century Tower, Ernst & Sohn, gante legeverden, ISBN4-473-01399-5) in GA Architect 13: Hiroshi Hara, A.D.A. Bognar, B.: „From Ritualistic Objects to Science Berlin 1992, pp. 141-59. Hakoosho, Kyoto 1995. Edita, Tokyo 1990, pp.
    [Show full text]
  • Vas-Cog Journaljournal
    JAPANESESOCIETYOFVASCULARCOGNITIVEIMPAIRMENT(2018NO.4) Vas-CogVas-Cog JournalJournal No.4 Apr 001.1. 2018 Official Journal of Vas-Cog Japan Society 1 ISSN:24239372 JAPANESESOCIETYOFVASCULARCOGNITIVEIMPAIRMENT(2018NO.4) Greetings from Vas-Cog Japan, the Japanese Society for Vascular Cognitive Impairment Ryuichi Morishita, MD, PhD President:TheJapaneseSocietyforVascularCognitiveImpairment IamDr.RyuichiMorishitafromOsakaUniversity, programatagreatvenueorganizedbythechairmen. andItookoverasPresidentoftheJapaneseSociety The9thannualmeetingistobeheldatBeppu forVascularCognitiveImpairmentfromDr.KojiAbe. InternationalConventionCenterAugust4-5,2018, Iwouldliketofurtherdevelopthissociety-which withDr.KatsuyaUrakamiandDr.EtsuroMatsubara wasfirstdevelopedbyDr.Nagata,thefirstPresident, aschairmen,soweareexpectingmanyofyouto andDr.Abe,thesecondPresident-tothebestofmy attend. ability,withthecooperationofallthemembersin OuraffiliateVas-CogAsiahasbeenrevitalizing oursociety,soyourkindsupportwouldbegreatly yearbyyear.The6thmeetingheldinNanjingCity appreciated. onOctober26,2017,wasahugesuccesswithVas- Vas-CogJapan,whichisinitseighthyearfromits CogAsiaDirector,Dr.KojiAbeandDr.Shinichiro timeasastudygroup,hasdevelopedquite Uchiyamaservingaslecturersandmoderators. The considerably. Asoursocietyhasalreadymetthe 7thannualmeetingwillbeheldinJakartaon requirementstoberegisteredasanacademic September6,2018.Vas-CogWorldwillalsobeheld organizationintheScienceCouncilofJapanwith inHongKongNovember24-27,2018. regardtothenumberofmembers,membership WithregardtothemajordementiassuchasLewy
    [Show full text]
  • AHST6333-FA13 Syllabus
    AHST6333 FA13 Urban Morphology AHST6333: Architectural History/Theory Seminar The Urban Morphology of Kyoto and New Orleans Instructors: Kentaro Tsubaki / TBD Introduction: Japanophile, spent 10 years as a journalist in New Or- leans prior to moving to Japan at the age of 40 never to “Like many of the Creole houses, the facade presented a return. He dedicates the rest of his life drawing awareness commonplace and unattractive aspect. The great green to the beauty and tranquility of pleasing customs and last- doors of the arched entrance were closed; and the green ing values of his adopted country at odds with the emerg- shutters of the balconied windows were half shut, like ing western style materialism. sleepy eyes lazily gazing upon the busy street below or the cottony patches of light clouds which floated slowly, Ignoring the obvious nouns identified with the location and slowly across the deep blue of the sky above. But beyond concentrating on the spatial relationships of Hearn’s re- the gates lay a little Paradise. The great court, deep and marks, the historical and geographical boundary becomes broad, was framed in tropical green; vines embraced the a blur, infinitely difficult to distinguish, transcending time white pillars of the piazza, and creeping plants climbed up and place. The goal of this study abroad studio is to re- the tinted walls to peer into the upper windows with their contextualize the familiar by dislocating to the unfamiliar. flower-eyes of flaming scarlet.” Kyoto is a city steeped in tradition and cultural heritage Lafacdio Hearn, “Creole Court, Leaves” From The Diary of an Impression- outside of the typical western society.
    [Show full text]
  • ME Week Program E Regular 20120210Web
    ME Week 2012 in Chiba - Program - 21 Feb. 2012 (Tuesday) 10:00 - 11:00 ME Week 2012 in Chiba Opening Ceremony Koichi ITO (Director of Research Center for Welcome Address Frontier Medical Engineering, Chiba University) Opening Remarks Yasushi SAITO (President of Chiba University) Kaname TAJIMA (Member of the House of Messages from Guests Representatives, Japan) Toshihito KUMAGAI (Mayor of Chiba City, Japan) Hisashi KATO (Director of International Program Department, Japan Sosiety for the Promotion Science) Shigeto ODA (Director of Deparment of Emergency and Critical Care Medicine / Vice Director of Research Center for Frontier Medical Engineering, Japan) An Introduction of Medical Engineering in Chiba Koichi ITO (Director of Research Center for University Frontier Medical Engineering, Chiba University) 11:00 - 12:00 Keynote Talk I "Translational Research Concept in Biomedical Engineering" Lecturer: Kerong DAI (Academician of China Engineering Academy, Shanghai JiaoTong University, Shanghai Ninth People’s Hospital, China) Chair: Kazuhisa TAKAHASHI (Chiba University, Japan) 12:00 - 13:00 Lunch 13:00 - 15:15 3T-in-3A 2012 and MECU 2012 Joint Sessions "Clinically-Driven Development of IT for Diagnosis and Bio-Modelling" Chair: See Kiong NG (Singapore University of Technology and Design, Singapore) Leading 13:00 - 13:35 L1-1: Fusion and Enrichment of Medical Imaging for High Hideaki HANEISHI (Chiba University, Japan) Quality Diagnosis and Treatment (FERMI) Clinically-Driven Research and Digital Technology Dongyun GU (Shanghai Jiao Tong University,
    [Show full text]
  • LIST of the WOOD PACKAGING MATERIAL PRODUCER for EXPORT 2005/03/01 Registration Number Registered Facility Address Phone
    LIST OF THE WOOD PACKAGING MATERIAL PRODUCER FOR EXPORT 2005/03/01 Registration number Registered Facility Address Phone 0001002 ITOS CORPORATION KAMOME-JIGYOSHO 62-1 KAMOME-CHO NAKA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045‐622‐1421 0001008 ISHIKAWA CO., LTD. YOKOHAMA FACTORY 18-24 DAIKOKU-CHO TSURUMI-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045‐521‐6171 THE IZUMI EXPRESS CO., LTD. TOKYO BRANCH, PACKING 0001011 8 DAIKOKU-FUTO TSURUMI-KU YOKOHAMA-SHI KANAGAWA, JAPAN 045‐504‐9431 CENTER HONMOKU B-2 WARE HOUSE, HONMOKU D-CFS 1 GO WARE HOUSE 3-1 0001012 INAGAKI CO., LTD. HONMOKU WORKS 045‐260‐1160 HONMOKU-FUTO NAKA-KU YOKOHAMA-SHI KANAGAWA, JAPAN 0001013 INOUE MOKUZAI CO., LTD. 895-3 SYAKE EBINA-SHI KANAGAWA, JAPAN 046‐236‐6512 0001016 UTOC CORPORATION HONMOKU B-1 OFFICE B-1, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045‐621‐5781 0001017 UTOC CORPORATION HONMOKU D-5 CFS 1-16, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045‐623‐1241 0001018 UTOC CORPORATION HONMOKU B-3 OFFICE B-3, HONMOKU-FUTOU, NAKA-KU, YOKOHAMA-SHI, KANAGAWA, JAPAN 045‐621‐6226 0001020 A.B. SHOHKAI CO., LTD. EBINA-JIGYOSHO 642 NAKANO EBINA-SHI KANAGAWA, JAPAN 046‐239‐0133 0001023 OSAKI CORP. TATEBAYASHI EIGYOUSHO 358 NOBE-MACHI TATEBAYASHI-SHI GUNMA, JAPAN 0276‐74‐6531 0001024 OSAKI CORP. OYAMA EIGYOUSHO 4-18-39 JYOUTOU OYAMA-SHI TOCHIGI, JAPAN 0285‐22‐1211 0001025 OSAKI CORP. NISHINASUNO EIGYOUSHO 429-9 NIKU-MACHI NISHINASUNO-CHO NASU-GUN TOCHIGI, JAPAN 0287‐37‐7161 0001028 OYAMA LUMBER CORPORATION 2-7-26 TENJIN-CHO OYAMA-SHI TOCHIGI, JAPAN 0285‐22‐0022 0001029 KAGAMI CO., LTD.
    [Show full text]
  • The Vitality and Resilience of Inherited Japanese Houses -100 Years of Shimizu-Gumi Houses-
    The Vitality and Resilience of Inherited Japanese Houses -100 Years of Shimizu-gumi Houses- Preface Since its foundation in 1804, residential architecture had been one of the primary business focuses for Shimizu-gumi, the present Shimizu Corporation. Many books have been published to showcase its works, such as Sekkei zushū, jūtaku no maki, ji 1907 nen shi 1923 nen (Drawing collection: house, from 1907 to 1923) and Sekkei zushū, shitsunai narabini kagu dentō no maki, ji 1909 nen shi 1913 nen (Drawing collection: interior, furniture and lighting, from 1909 to 1913). These books feature painted drawings of large houses, which could be considered mansions in the Western sense, designed and built by Shimizu-gumi, and include plans, elevations, development plans, and illustrations of furniture. The books enable the reader to visualize many aspects of mansions in the Meiji era (1868-1912) and Taisho era (1912-1926,) and to understand how these mansions were significant as elements of urban culture. Additionally, an academic work based on these earlier texts was published to commemorate the 60th anniversary of the Housing Research Foundation JUSOKEN: Meiji/Taisho no teitaku, Shimizu-gumi sakusei saishiki-zu no sekai (Mansions in Meiji and Taisho, the world of colored drawings created by Shimizu-gumi, Kashiwashobo, 2009, currently unavailable). This book is the product of joint research by “Shimizu Kensetsu Teitaku Shiryō Kenkyūkai” (Shimizu Corporation Mansion Document Study Group, 2004 to 2009) in the “Jūtaku Shiryō Iinkai” (Committee for historical materials about houses) of Jusoken. For the next phase of study, surveys and research on Jūtaku kenchiku zushū (Residential architecture catalog, 1st volume: 1935, 2nd volume: 1939) should be conducted.
    [Show full text]